William James Enright
Independent DirectorMr. William James Enright, also known as Bill, MBA, is an Independent Director of Bullfrog AI Holdings, Inc. from February 14, 2023. He had been the Principal Financial Officer of Barinthus Biotherapeutics plc since May 01, 2025 until May 01, 2026 and had been its Secretary from September 29, 2025. He serves as Chief Executive Officer & Director of Barinthus Biotherapeutics plc (formerly known as Vaccitech plc) since August 2019. He has breadth of experiences in a variety of positions within the life science/biotech industry, including time as a consultant, a bench scientist and several years with Life Technologies, Inc. (acquired by Thermo-Fisher), working in various senior level licensing, business management, manufacturing and research roles. Mr. Enright served as the Chief Executive Officer at Altimmune, Inc. (formerly Vaxin, Inc.) since August 2008 until November 30, 2018 and served as its President until November 30, 2018. Mr. Enright served as the Director at Altimmune, Inc. since May 2017. He is Member of Advisory Board at Frederick Innovative Technology Center, Inc. Mr. Enright received a Master of Arts in Molecular Biology and BS in Biology from SUNY at Buffalo and a Master of Science in Business Management from Johns Hopkins University. He is a seasoned biotech executive with experience in building and financing both privately held and publicly held companies. He spent six years with GenVec, Inc. (acquired by Intrexon) with increasing responsibilities, which included a role as Head of Business Development.
Positions
- Company NameBullfrog AI Holdings, Inc.Stock CodeBFRGPositionIndependent DirectorRelated SecuritiesColleagues
- VSVininder SinghFounder, Chairman & CEO
- JBJoshua BlacherChief Financial Officer
- JTJ. T. KoffenbergerHead of Information Technology
- CSCetin SavkliChief AI Advisor & Member of Advisory Board
- EREric RoosSVP of Business Development & Corporate Strategy
- RDR. Donald ElseyIndependent Director
- JDJason D. HansonIndependent Director
